| Serial Number | 79314153 |
| Word Mark | 272BIO |
| Filing Date | Tuesday, April 13, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 1, 2022 |
| Registration Number | 6886491 |
| Registration Date | Tuesday, November 1, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 16, 2022 |
| Goods and Services | Custom manufacture of veterinary preparations and medical preparations; custom manufacture of pharmaceutical preparations for veterinary and medical use; custom manufacture of biological preparations for veterinary and medical use; custom manufacture of biotechnological preparations for veterinary and medical use; custom manufacture of medicines including biotherapeutic medicines |
| Goods and Services | Veterinary preparations for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; medical preparations for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; pharmaceutical preparations for veterinary and/or medical use for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; biological preparations for veterinary and medical use for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; biotechnological preparations for veterinary and medical use for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals; medicines, namely, antibody therapeutic preparations and veterinary vaccines for livestock; biotherapeutic medicines for the prevention and treatment of autoimmune diseases, central nervous system diseases, cancer, hematologic diseases, metabolic disorders, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, genetic conditions, inflammatory diseases, ophthalmological conditions, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain, and psychiatric disorder in livestock and other animals |
| Pseudo Mark | 272 BIO; TWO HUNDRED SEVENTY TWO BIO; TWO SEVEN TWO BIO |
| Goods and Services | Scientific research and development; biotechnological research and development; biotechnological research and development relating to animals and livestock; biotherapeutic product development; medical and veterinary laboratory services; clinical research in the field of veterinary preparations, biotherapeutic medicines, and antibodies; conducting clinical trials for others; information, advice and consultancy relating to the aforesaid services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 14, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 28, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | 272BIO Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | GB |
| Party Name | 272BIO Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | GB |
| Party Name | 272BIO Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | GB |
| Event Date | Event Description |
| Tuesday, March 14, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, February 22, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, February 22, 2023 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 1, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 1, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 1, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 23, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 16, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 16, 2022 | PUBLISHED FOR OPPOSITION |
| Friday, August 12, 2022 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Wednesday, July 27, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, July 27, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 27, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Thursday, July 14, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 14, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, July 14, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 14, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 14, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, June 20, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 20, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 20, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, January 23, 2022 | REFUSAL PROCESSED BY IB |
| Thursday, January 6, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, January 6, 2022 | REFUSAL PROCESSED BY MPU |
| Thursday, December 9, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, December 8, 2021 | NON-FINAL ACTION WRITTEN |
| Saturday, December 4, 2021 | ASSIGNED TO EXAMINER |
| Friday, July 2, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, June 28, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 25, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |